Literature DB >> 7505893

Effects of DSP-4 on monoamine and monoamine metabolite levels and on beta adrenoceptor binding kinetics in rat brain at different times after administration.

C N Theron1, A S de Villiers, J J Taljaard.   

Abstract

Effects of DSP-4 on noradrenaline (NA), 3-methoxy-4-hydroxyphenyl glycol (MHPG), serotonin (5-HT) and 5-hydroxyindole acetic acid (5-HIAA) levels and on beta adrenoceptor binding kinetics (Bmax and KD) in rat hippocampus, cortex and hypothalamus were studied between 24 hours and 14 days after systemic administration. Beta adrenoceptor numbers in hippocampus and cortex, but not in hypothalamus, were significantly increased after DSP-4. No significant changes in KD values were observed in hypothalamus, but significant increases in this parameter were measured in hippocampus and cortex. NA and MHPG levels were significantly decreased in all three brain regions, but MHPG/NA ratios were increased in hippocampus, decreased in cortex and unchanged in hypothalamus. Very prominent increases in 5-HIAA levels were observed in all three brain regions, but only at one day after DSP-4. The greatest increases in 5-HIAA levels occurred in the hippocampus, but this effect of DSP-4 appeared to be slightly diminished by pre-treatment with fluoxetine. In cortex and hippocampus 5-HT levels were slightly, but significantly decreased after DSP-4.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7505893     DOI: 10.1007/bf00975054

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  26 in total

Review 1.  The interaction of the beta-haloethyl benzylamines, xylamine, and DSP-4 with catecholaminergic neurons.

Authors:  M W Dudley; B D Howard; A K Cho
Journal:  Annu Rev Pharmacol Toxicol       Date:  1990       Impact factor: 13.820

2.  Repeated electroconvulsive shock prevents increased neocortical beta 1-adrenoceptor binding after DSP-4 treatment in rats.

Authors:  D J Dooley; D J Heal; G M Goodwin
Journal:  Eur J Pharmacol       Date:  1987-02-24       Impact factor: 4.432

3.  Effect of corticosterone on noradrenergic nuclei in the pons-medulla and [3H]NA release from terminals in hippocampal slices.

Authors:  A S de Villiers; V A Russell; J J Taljaard
Journal:  Neurochem Res       Date:  1992-03       Impact factor: 3.996

4.  Comparative effects of the neurotoxins N-chloroethyl-N-ethyl-2-bromobenzylamine hydrochloride (DSP4) and 6-hydroxydopamine on hypothalamic noradrenergic, dopaminergic and 5-hydroxytryptaminergic neurons in the male rat.

Authors:  K J Lookingland; D S Chapin; D W McKay; K E Moore
Journal:  Brain Res       Date:  1986-02-19       Impact factor: 3.252

5.  Dopamine metabolites in rat cisternal cerebrospinal fluid: major contribution from extrastriatal dopamine neurones.

Authors:  P H Hutson; G Curzon
Journal:  J Neurochem       Date:  1986-01       Impact factor: 5.372

6.  Pharmacological characterization of presynaptic alpha-adrenoceptors modulating [3H]noradrenaline and [3H]5-hydroxytryptamine release from slices of the hippocampus of the rat.

Authors:  A L Frankhuyzen; A H Mulder
Journal:  Eur J Pharmacol       Date:  1982-06-16       Impact factor: 4.432

7.  Brain (Na+,K+)-ATPase and noradrenergic function: recovery of enzyme activity after norepinephrine depletion.

Authors:  A C Swann
Journal:  Brain Res       Date:  1984-11-12       Impact factor: 3.252

8.  A low dose of xylamine produces sustained and selective decreases in rat brain norepinephrine without evidence of neuronal degeneration.

Authors:  M W Dudley; B W Siegel; A M Ogden; D R McCarty
Journal:  J Pharmacol Exp Ther       Date:  1988-10       Impact factor: 4.030

9.  DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)--a useful denervation tool for central and peripheral noradrenaline neurons.

Authors:  G Jonsson; H Hallman; F Ponzio; S Ross
Journal:  Eur J Pharmacol       Date:  1981-06-19       Impact factor: 4.432

View more
  4 in total

1.  Lesioning noradrenergic neurons of the locus coeruleus in C57Bl/6 mice with unilateral 6-hydroxydopamine injection, to assess molecular, electrophysiological and biochemical changes in noradrenergic signaling.

Authors:  P Szot; L Knight; A Franklin; C Sikkema; S Foster; C W Wilkinson; S S White; M A Raskind
Journal:  Neuroscience       Date:  2012-04-25       Impact factor: 3.590

2.  Selective loss of noradrenaline exacerbates early cognitive dysfunction and synaptic deficits in APP/PS1 mice.

Authors:  Thea Hammerschmidt; Markus P Kummer; Dick Terwel; Ana Martinez; Ali Gorji; Hans-Christian Pape; Karen S Rommelfanger; Jason P Schroeder; Monika Stoll; Joachim Schultze; David Weinshenker; Michael T Heneka
Journal:  Biol Psychiatry       Date:  2012-08-09       Impact factor: 13.382

3.  A comprehensive analysis of the effect of DSP4 on the locus coeruleus noradrenergic system in the rat.

Authors:  P Szot; C Miguelez; S S White; A Franklin; C Sikkema; C W Wilkinson; L Ugedo; M A Raskind
Journal:  Neuroscience       Date:  2010-01-04       Impact factor: 3.590

4.  Sequential Loss of LC Noradrenergic and Dopaminergic Neurons Results in a Correlation of Dopaminergic Neuronal Number to Striatal Dopamine Concentration.

Authors:  Patricia Szot; Allyn Franklin; Carl Sikkema; Charles W Wilkinson; Murray A Raskind
Journal:  Front Pharmacol       Date:  2012-10-22       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.